Investor

After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO

After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO

17 hours ago   |   Xconomy   |   2 articles

It's been a busy week for Repare Therapeutics. On Tuesday, the cancer drug developer struck up an alliance with Bristol Myers Squibb that pays $65 million now and as much as $3...
Read more ...

Cardiff's quiet tech investor, Bill Maris, recruits ex-Googlers to Section 32

1 day ago   |   San Diego Biotechnology

Section 32 builds out high-profile team managing culture and reputation of the growing investment group...
Read more ...

Halozyme To Present At Upcoming Virtual Investor Conferences

2 days ago   |   San Diego Biotechnology

SAN DIEGO, May 28, 2020 /PRNewswire/ - Halozyme Therapeutics, Inc. today announced that Dr. Helen Torley, president and chief executive officer, will be participating in the...
Read more ...

AbCellera Raises $105M to Advance Antibody Discovery Operations

AbCellera Raises $105M to Advance Antibody Discovery Operations

2 days ago   |   Xconomy

Most of the best-selling drugs worldwide today are antibodies, and in the three decades-plus since the first such drug was approved, makers of such treatments have begun...
Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

3 days ago   |   San Diego Biotechnology   |   2 articles

SAN DIEGO, May 27, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and...
Read more ...

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

3 days ago   |   Xconomy

A stem cell biologist, a gene editing expert, and a data engineer walk into a room...and that's just a few of the people Daphne Koller has recruited in the past two years to...
Read more ...

Director, Investor Relations & Communications-Biotechnology - AceIt Strategies! - San Diego, CA

10 days ago   |   San Diego Biotechnology   |   7 articles

Develop and manage pitch materials and conduct media outreach to healthcare, biotech and business reporters (gaining broad experience with the media over time).From AceIt...
Read more ...

With $30M, Octant Launches Synthetic Bio Search for Multi-Target Drugs

With $30M, Octant Launches Synthetic Bio Search for Multi-Target Drugs

10 days ago   |   Xconomy

Octant, a new drug discovery company, launched Wednesday with millions in backing from tech investors to push ahead plans to leverage advances in science and in tech-including...
Read more ...

Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases

Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases

11 days ago   |   Xconomy

One of the risks to a newborn's life comes from the mother's immune system. It attacks the platelets of the fetus, depleting these blood-clotting cells and risking...
Read more ...

Amplyx Adds Cash from Pfizer, Adage as Funding Round Tops $90M

Amplyx Adds Cash from Pfizer, Adage as Funding Round Tops $90M

11 days ago   |   Xconomy   |   2 articles

Amplyx Pharmaceuticals has completed enrollment in one mid-stage trial of its lead drug candidate, a new kind of antifungal treatment, and has finished treating the first...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

Forma Therapeutics has developed a pipeline of small molecules aimed at rare blood disorders and cancers, but it aims to advance two-investigational treatments for sickle cell... Read more ...

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

A year ago about 40,000 people gathered in Chicago for the annual meeting of the American Society of Clinical Oncology. Today a virtual version of the ASCO conference, the... Read more ...

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

An AbbVie drug that treats pain in the uterus has notched an additional FDA approval for addressing heavy menstrual bleeding associated with uterine fibroids. The regulatory... Read more ...

Daya Bay Reactor Experiment Continues to Generate Data

Daya Bay Reactor Experiment Continues to Generate Data

Antineutrino detectors are submersed in liquid at the Daya Bay experiment, as seen during the final phase of construction in August 2012. Experiment: Daya Bay reactor neutrino... Read more ...

Seeing Cancer, But Not Through a Microscope

Seeing Cancer, But Not Through a Microscope

Toward the end of the 19th century, a French doctor named Ernest Besnier coined the term “ biopsy ,” combining the Greek bios and opsis. In the decades since, clinicians have... Read more ...

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Human DNA holds secrets that, once uncovered, have led scientists to develop a number of treatments for disease. A slew of biopharmas and biotechs-not to mention national... Read more ...

Don't Wait for “Them” to Find Your Weaknesses

Don't Wait for “Them” to Find Your Weaknesses

Our Professional Services Written by: Crystal Booth, M.M.- Regional Manager, Southeast USA at PSC Biotech We've probably all heard the phrase “audit ready state”. But what does... Read more ...

Functional oral nanoparticles for delivering silibinin and cryptotanshinone...

Breast cancer lung metastasis occurs in more than 60% of all patients with breast cancer, and most of those afflicted by it eventually die of recurrence. The tumor... Read more ...

Escherichia coli metabolism under short-term repetitive substrate dynamics...

Microbial metabolism is highly dependent on the environmental conditions. Especially, the substrate concentration, as well as oxygen availability, determine the metabolic... Read more ...

High-yield production of l-serine through a novel identified exporter...

L-Serine has wide and increasing applications in industries with fast-growing market demand. Although strategies for achieving and improving l-serine production in... Read more ...